Skip to main content

and
  1. No Access

    Article

    Continuous delivery of rotigotine decreases extracellular dopamine suggesting continuous receptor stimulation

    Rotigotine, a non-ergolinic dopamine receptor agonist for treatment of Parkinson’s disease was continuously administered over 48 h (0.5 mg/kg s.c., slow release formulation) to conscious rats striatally implan...

    J. Kehr, X.-J. Hu, M. Goiny, D. K. A. Scheller in Journal of Neural Transmission (2007)